Skip to main content
. Author manuscript; available in PMC: 2015 Jul 28.
Published in final edited form as: Microvasc Res. 2013 Feb 26;87:58–64. doi: 10.1016/j.mvr.2013.02.005

Figure 4.

Figure 4

Cutaneous vascular conductance (ΔCVC %baseline 3)- in (A) normotensive controls and (B) essential hypertensive subjects at baseline (BL; during drug perfusion), and during a local cooling protocol to 24°C at the control site, ROCK inhibited, adrenoceptor inhibited, and ROCK + adrenoceptor inhibited. Values significantly different from normotensive group: Control site ** p<0.001; ROCK + Adrenergic Inhibited site p<0.05, †† p<0.01, ††† p<0.001.